CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Trade Payables History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Trade Payables | ₹2,837 Cr | ₹2,474 Cr | ₹2,535 Cr | ₹2,508 Cr | ₹2,067 Cr |
What is the latest Trade Payables ratio of CIPLA ?
| Year | Trade Payables |
|---|---|
| Mar2025 | ₹2,837 Cr |
| Mar2024 | ₹2,474 Cr |
| Mar2023 | ₹2,535 Cr |
| Mar2022 | ₹2,508 Cr |
| Mar2021 | ₹2,067 Cr |
How is Trade Payables of CIPLA Trending?
| Years | Trade Payables | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,837 Cr | 14.69 | |
| Mar2024 | ₹2,474 Cr | -2.39 | |
| Mar2023 | ₹2,535 Cr | 1.05 | |
| Mar2022 | ₹2,508 Cr | 21.35 | |
| Mar2021 | ₹2,067 Cr | - | |
Compare Trade Payables of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹99,327.1 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| MANKIND PHARMA | ₹85,816.7 Cr | 3% | -3.9% | -15.4% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 2.4% |
-7.2% |
-18.1% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses